episodes classified as atrial tachycardia. The AF Suppression Algorithm reduced symptomatic AF burden from 2.50% in the control group to 1.87% in the treatment group, a relative difference of 25%.

A novel drug combination, improvements in quality of life, and breakthrough hemolysis control are among the clinical highlights in paroxysmal ... Compared with anti-C5 treatment, the drug led ...

After hours: 7:57:01 p.m. EST ...